Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.

Kyvernitakis, I; Ziller, V; Hars, O; Bauer, M; Kalder, M; Hadji, P

Kyvernitakis, I; Ziller, V; Hars, O; Bauer, M; Kalder, M; Hadji, P.

Affiliation

Kyvernitakis I; Department of Gynecological Endocrinology, Reproductive Medicine and Osteoporosis , Phillips University of Marburg, Marburg , Germany.

Climacteric ; 17(3): 252-9, 2014 Jun.

Article in En | MEDLINE | ID: mdl-23805799

Subject(s)

Antineoplastic Agents, Hormonal/adverse effects; Aromatase Inhibitors/adverse effects; Breast Neoplasms/drug therapy; Medication Adherence; Aged; Anastrozole; Anxiety/chemically induced; Chemotherapy, Adjuvant; Female; Hot Flashes/chemically induced; Humans; Letrozole; Middle Aged; Musculoskeletal Pain/chemically induced; Nitriles/adverse effects; Sleep Wake Disorders/chemically induced; Time Factors; Triazoles/adverse effects; Urinary Bladder Diseases/chemically induced; Vaginal Diseases/chemically induced

Key words

ADHERENCE; AROMATASE INHIBITORS; BREAST CANCER; MENOPAUSAL SYMPTOMS; POSTMENOPAUSAL

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents, Hormonal / Aromatase Inhibitors / Medication Adherence Type of study: Clinical_trials / Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Climacteric Journal subject: GINECOLOGIA Year: 2014 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google